CN105219697A - A kind of people's primary keratinocyte is separated the method for preparation - Google Patents

A kind of people's primary keratinocyte is separated the method for preparation Download PDF

Info

Publication number
CN105219697A
CN105219697A CN201410321577.2A CN201410321577A CN105219697A CN 105219697 A CN105219697 A CN 105219697A CN 201410321577 A CN201410321577 A CN 201410321577A CN 105219697 A CN105219697 A CN 105219697A
Authority
CN
China
Prior art keywords
cell
keratinocyte
primary
cells
dksfm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410321577.2A
Other languages
Chinese (zh)
Inventor
刘洪�
李琳
杨熙
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
H&B HEALTH GROUP
Original Assignee
H&B HEALTH GROUP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H&B HEALTH GROUP filed Critical H&B HEALTH GROUP
Priority to CN201410321577.2A priority Critical patent/CN105219697A/en
Publication of CN105219697A publication Critical patent/CN105219697A/en
Pending legal-status Critical Current

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention discloses a kind of method that people's primary keratinocyte is separated preparation, it comprises the following steps: (1) primary keratinocyte is separated; (2) primary keratinocyte is cultivated; (3) primary keratinocyte is frozen; (4) primary keratinocyte Activity determination.Keratinocyte provided by the invention is separated the method for preparation, adopt the special culture system of serum-free keratinocyte that DKSFM composition limits, not containing bovine serum composition and trophocyte, avoid the introducing of inhuman source activity albumen and other biotic component, make downstream research system more single; Direct frozen primary cell, after recovery, cell has higher survival rate, serum-free keratinocyte special culture media simultaneously owing to adopting composition to limit, decrease the factor content promoting cytodifferentiation, be conducive to the prolongation in keratinocyte vitro culture cycle, show more doublings, make downstream research system more stable.

Description

A kind of people's primary keratinocyte is separated the method for preparation
Technical field
The present invention relates to a kind of method that people's primary keratinocyte is separated preparation.
Background technology
Human keratinized cell is the main cell of group adult epidermal, because the epidermal sheet cultivated may be used for various skin disease such as clinical transplantation treatment burn, vitiligo etc., obtain people's epidermal keratinocyte of stablizing high viability for basic and clinical study is all very important.Keratinocyte separation general at present and culture system can introduce the composition in inhuman source mostly, such as use serum and trophocyte, greatly bring security risk.Keratinocyte is a kind of primary cell of the very easy differentiation of end eventually simultaneously, and as research object, often needs reasonable stability and passage capacity, and this improves separation and culture system with regard to needs.
Summary of the invention
The technical problem to be solved in the present invention is the defect overcoming prior art, provides a kind of keratinocyte to be separated the method for preparation.
In order to solve the problems of the technologies described above, the invention provides following technical scheme:
A kind of people's primary keratinocyte of the present invention is separated the method for preparation, and it comprises the following steps:
(1) primary keratinocyte is separated: get fresh skin sample through ethanol disinfection, remove skin surface microbiological contamination, clean several times with phosphate buffered saline buffer afterwards, remove the residual ethanol on sample, sample is cut into the molecule of 1.8 ~ 2.2mm diameter; With the collagen protein ferment treatment gained molecule that the work of 35 ~ 45mL enzyme is 150-300U/mL, 4 DEG C of placements of spending the night; Collecting by filtration containing the face tissue of keratinocyte, and puts into pancreas enzyme-EDTA 35 ~ 40 DEG C process 1-3 hour, separate keratinocytes; Centrifugal collecting cell precipitation under rotating speed is 1800rpm; With 40mLDMEM cell culture medium washed cell 2 times; The skin cells keratinocyte special culture solution DKSFM collected is resuspended, uses blood-counter system to calculate cell quantity and activity; According to 5 × 10 4cells/cm 2being seeded in diameter is 100mm Tissue Culture Dish;
(2) primary keratinocyte is cultivated: latter 2nd day of inoculation, observation of cell adherent growth state under inverted microscope, record growth conditions; After cell inoculation, every day changes fresh culture; Cell inoculation observed and recorded cell attachment growing state rear every day;
(3) primary keratinocyte is frozen: the degree of converging reaching 60-90% after cell inoculation culture 3-7 days, discards substratum, clean several times with phosphate buffered saline buffer; With 5mLTrypLE process cell, at 37 DEG C, 5-10 minute; Basis of microscopic observation cellular contraction situation, become after circle until all cells and add 10mLDKSFM, slight piping and druming makes cell dispersal become suspension, takes out 100ul cell and carries out cell counting, centrifugal collecting cell precipitation under 1800rpm; 90%DKSFM+10%DMSO configures cells frozen storing liquid, according to cell counts, according to 1 × 10 6cells/mL adds cells frozen storing liquid, and re-suspended cell inserts Programmed cryopreservation box, puts into subzero 80 DEG C of Ultralow Temperature Freezer frozen overnight cells; From upper step freezing storing box, take out cell, put into the medium-term and long-term preservation of liquid nitrogen container, and record preserve batch and quantity;
(4) primary keratinocyte Activity determination: choose arbitrarily 1 pipe from a collection of frozen primary keratinocyte, cell is melted rapidly in 37 C water bath, add not containing antibiotic DKSFM cell culture fluid, take out the calculating that 100ul carries out cell quantity and survival rate; Cell suspension 1800rpm is centrifugal, and collecting cell precipitates; DKSFM re-suspended cell, makes cell dispersed, inoculating cell culture dish; The CO of 5% is adopted afterwards at 37 DEG C 2cultivate; Example of spatial compartmentalizationis, when reaching 40-60% to cell confluency degree, changes replaced medium every day into; Every day is by inverted microscope observation of cell growth conditions and whether bacteriological infection situation, and Taking Pictures recording; When cell confluency degree reaches 60-90%, passage cell; Cell continues to be cultured to and breaks up completely, when stopping propagation, according to initiator cell quantity when final cell quantity and recovery, calculates multiplication cycle and number of times.
The beneficial effect that the present invention reaches is:
(1) the special culture system of serum-free keratinocyte adopting DKSFM (Definedkeratinocyte-SFM) composition to limit, not containing bovine serum composition and trophocyte, avoid the introducing of inhuman source activity albumen and other biotic component, make downstream research system more single;
(2) direct frozen primary cell, after recovery, cell has higher survival rate, can up to more than 75%, serum-free keratinocyte special culture media simultaneously owing to adopting composition to limit, decrease the factor content promoting cytodifferentiation, be conducive to the prolongation in keratinocyte vitro culture cycle, show more doublings, be greater than 26 times, make downstream research system more stable.
Embodiment
Below the preferred embodiments of the present invention are described, should be appreciated that preferred embodiment described herein is only for instruction and explanation of the present invention, is not intended to limit the present invention.
A kind of keratinocyte of the present invention is separated the method for preparation, and it comprises the following steps:
(1) primary keratinocyte is separated: get fresh postoperative dermatological specimens of peritomizing through ethanol disinfection, remove skin surface microbiological contamination, clean several times with phosphate buffered saline buffer afterwards, remove the residual ethanol on sample, sample is cut into the molecule of 2mm diameter; With the collagen protein ferment treatment gained molecule that the work of 35 ~ 45mL enzyme is 150-300U/mL, 4 DEG C of placements of spending the night; Collecting by filtration containing the face tissue of keratinocyte, and puts into pancreas enzyme-EDTA 35 DEG C process 1 hour, separate keratinocytes; Centrifugal collecting cell precipitation under rotating speed is 1800rpm; With 40mLDMEM (high sugar) cell culture medium washed cell 2 times; The skin cells collected is (containing a large amount of keratinocyte, a small amount of melanophore and inoblast etc.) use keratinocyte special culture solution DKSFM (Gibco, ThermoFisher, USA) resuspended, use blood-counter system to calculate cell quantity and activity; According to 5 × 10 4cells/cm 2being seeded in diameter is 100mm Tissue Culture Dish (Corning, USA);
(2) primary keratinocyte is cultivated: within the 2nd day, rise after inoculation, observe and record cell attachment growth conditions under inverted microscope; After cell inoculation, every day changes fresh culture; Cell inoculation observed and recorded cell attachment growing state rear every day;
(3) primary keratinocyte is frozen: reach the degree of converging of 60% after cell inoculation culture 3-7 days, discard substratum, clean several times with phosphate buffered saline buffer; Cell is processed with 5mLTrypLE (Gibco, ThermoFisher, USA), at 37 DEG C, 5-10 minute; Basis of microscopic observation cellular contraction situation, become after circle until all cells and add 10mLDKSFM, slight piping and druming makes cell dispersal become suspension, takes out 100ul cell and carries out cell counting, centrifugal collecting cell precipitation under 1800rpm; 90%DKSFM+10%DMSO configures cells frozen storing liquid, according to cell counts, according to 1X10 6cells/mL adds cells frozen storing liquid, and re-suspended cell inserts Programmed cryopreservation box, puts into subzero 80 DEG C of Ultralow Temperature Freezer frozen overnight cells; From upper step freezing storing box, take out cell, put into the medium-term and long-term preservation of liquid nitrogen container, and record preserve batch and quantity;
(4) primary keratinocyte Activity determination: choose arbitrarily 1 pipe from a collection of frozen primary keratinocyte, cell is melted rapidly in 37 C water bath, add not containing antibiotic DKSFM cell culture fluid, take out the calculating (viable cell/total cellular score) that 100ul carries out cell quantity and survival rate; Cell suspension 1800rpm is centrifugal, and collecting cell precipitates; DKSFM re-suspended cell, makes cell dispersed, inoculating cell culture dish; The CO of 5% is adopted afterwards at 37 DEG C 2cultivate; Example of spatial compartmentalizationis, when reaching 40-60% to cell confluency degree, changes replaced medium every day into; Every day is by inverted microscope observation of cell growth conditions and whether bacteriological infection situation, and Taking Pictures recording; When cell confluency degree reaches 60%, passage cell; Cell continues to be cultured to and breaks up completely, when stopping propagation, according to initiator cell quantity when final cell quantity and recovery, calculates multiplication cycle and number of times.
Last it is noted that the foregoing is only the preferred embodiments of the present invention, be not limited to the present invention, although with reference to previous embodiment to invention has been detailed description, for a person skilled in the art, it still can be modified to the technical scheme described in foregoing embodiments, or carries out equivalent replacement to wherein portion of techniques feature.Within the spirit and principles in the present invention all, any amendment done, equivalent replacement, improvement etc., all should be included within protection scope of the present invention.

Claims (1)

1. people's primary keratinocyte is separated a method for preparation, it is characterized in that, comprises the following steps:
(1) primary keratinocyte is separated: get fresh skin sample through ethanol disinfection, remove skin surface microbiological contamination, clean several times with phosphate buffered saline buffer afterwards, remove the residual ethanol on sample, sample is cut into the molecule that diameter is 2mm; With the collagen protein ferment treatment gained molecule that the work of 35 ~ 45mL enzyme is 150-300U/mL, 4 DEG C of placements of spending the night; Collecting by filtration containing the face tissue of keratinocyte, and puts into pancreas enzyme-EDTA 35 ~ 40 DEG C process 1-3 hour, separate keratinocytes; Centrifugal collecting cell precipitation under rotating speed is 1800rpm; With 40mLDMEM cell culture medium washed cell 2 times; The skin cells keratinocyte special culture solution DKSFM collected is resuspended, uses blood-counter system to calculate cell quantity and activity; Be adjusted to 5 × 10 4cells/cm 2after to be seeded in diameter be on 100mm Tissue Culture Dish;
(2) primary keratinocyte is cultivated: latter 2nd day of inoculation, observation of cell adherent growth state under inverted microscope, record growth conditions; After cell inoculation, every day changes fresh DKSFM substratum; Cell inoculation observed and recorded cell attachment growing state rear every day;
(3) primary keratinocyte is frozen: the degree of converging reaching 60-90% after cell inoculation culture 3-7 days, discards substratum, clean several times with phosphate buffered saline buffer; With 5mLTrypLE process cell, at 37 DEG C, 5-10 minute; Basis of microscopic observation cellular contraction situation, become after circle until all cells and add 10mLDKSFM, slight piping and druming makes cell dispersal become suspension, takes out 100ul cell and carries out cell counting, centrifugal collecting cell precipitation under 1800rpm; 90%DKSFM+10%DMSO configures cells frozen storing liquid, according to cell counts, according to 1 × 10 6cells/mL adds cells frozen storing liquid, and re-suspended cell inserts Programmed cryopreservation box, puts into subzero 80 DEG C of Ultralow Temperature Freezer frozen overnight cells; From upper step freezing storing box, take out cell, put into the medium-term and long-term preservation of liquid nitrogen container, and record preserve batch and quantity;
(4) primary keratinocyte Activity determination: choose arbitrarily 1 pipe from a collection of frozen primary keratinocyte, cell is melted rapidly in 37 C water bath, add not containing antibiotic DKSFM cell culture fluid, take out the calculating that 100ul carries out cell quantity and survival rate; Cell suspension 1800rpm is centrifugal, and collecting cell precipitates; DKSFM re-suspended cell, makes cell dispersed, inoculating cell culture dish; The CO of 5% is adopted afterwards at 37 DEG C 2cultivate; Example of spatial compartmentalizationis, when reaching 40-60% to cell confluency degree, changes replaced medium every day into; Every day is by inverted microscope observation of cell growth conditions and whether bacteriological infection situation, and Taking Pictures recording; When cell confluency degree reaches 60-90%, passage cell; Cell continues to be cultured to and breaks up completely, when stopping propagation, according to initiator cell quantity when final cell quantity and recovery, calculates multiplication cycle and number of times.
CN201410321577.2A 2014-07-04 2014-07-04 A kind of people's primary keratinocyte is separated the method for preparation Pending CN105219697A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410321577.2A CN105219697A (en) 2014-07-04 2014-07-04 A kind of people's primary keratinocyte is separated the method for preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410321577.2A CN105219697A (en) 2014-07-04 2014-07-04 A kind of people's primary keratinocyte is separated the method for preparation

Publications (1)

Publication Number Publication Date
CN105219697A true CN105219697A (en) 2016-01-06

Family

ID=54988968

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410321577.2A Pending CN105219697A (en) 2014-07-04 2014-07-04 A kind of people's primary keratinocyte is separated the method for preparation

Country Status (1)

Country Link
CN (1) CN105219697A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115354015A (en) * 2022-07-13 2022-11-18 北京康曦健康医学研究院 Method for adherent culture of human epidermal keratinocytes by using electromagnetic field

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4940666A (en) * 1983-07-15 1990-07-10 University Patents, Inc. Process and defined medium for growth of human epidermal keratinocyte cells
WO1999054435A2 (en) * 1998-04-17 1999-10-28 Societe Des Produits Nestle Immortalised cell lines derived from normal human skin tissues
CN1560235A (en) * 2004-02-17 2005-01-05 华东理工大学 Non serum substratum for in vitro culture and amplification of cutaneous keratin cell
CN1562392A (en) * 2004-03-24 2005-01-12 华东理工大学 Method for fabricating activated artificial skin tissue in bilayer by using bioreactor
CN1571835A (en) * 2001-10-17 2005-01-26 贝林格尔英格海姆法玛两合公司 Keratinocytes which may be used as biologically active substances for the treatment of wounds

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4940666A (en) * 1983-07-15 1990-07-10 University Patents, Inc. Process and defined medium for growth of human epidermal keratinocyte cells
WO1999054435A2 (en) * 1998-04-17 1999-10-28 Societe Des Produits Nestle Immortalised cell lines derived from normal human skin tissues
CN1571835A (en) * 2001-10-17 2005-01-26 贝林格尔英格海姆法玛两合公司 Keratinocytes which may be used as biologically active substances for the treatment of wounds
CN1560235A (en) * 2004-02-17 2005-01-05 华东理工大学 Non serum substratum for in vitro culture and amplification of cutaneous keratin cell
CN1562392A (en) * 2004-03-24 2005-01-12 华东理工大学 Method for fabricating activated artificial skin tissue in bilayer by using bioreactor

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
刘艳芳等: "《临床病毒学检验》", 30 April 2009, 军事医学科学出版社 *
卢宁等: "实验室条件下人角质形成细胞的培养技术", 《中国临床康复》 *
吴国选等: "人皮肤角质形成细胞库的构建", 《实用医药杂志》 *
孙文娟等: "人皮肤角质形成细胞和成纤维细胞的原代培养和鉴定的实验研究", 《潍坊医学院学报》 *
方圣等: "人角质形成细胞体外分离与无血清培养的实验研究", 《中国现代医学杂志》 *
李伟等: "人角质形成细胞库的建立", 《第三军医大学学报》 *
金岩: "《组织工程学原理与技术》", 30 June 2004, 第四军医大学出版社 *
陈勇等: "人皮肤角质形成细胞的分离与原代无血清培养", 《湖南医科大学学报》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115354015A (en) * 2022-07-13 2022-11-18 北京康曦健康医学研究院 Method for adherent culture of human epidermal keratinocytes by using electromagnetic field

Similar Documents

Publication Publication Date Title
TWI773693B (en) A method of isolating mesenchymal stem cells from the amniotic membrane of the umbilical cord, a mesenchymal stem cell population isolated from the amniotic membrane of the umbilical cord and a cell culture medium for isolating mesenchymal stem cells from the amniotic membrane of the umbilical cord
CN102660497B (en) Method for freezing and reviving umbilical cord tissues and for separating and increasing stem cells
CN103275922B (en) A kind of fine-wool sheep hair follicle stem cells isolated culture method
CN102807966A (en) Method for freezing and thawing placental whole cells and separating and expanding stem cells
CN102660502A (en) Methods for freezing and thawing whole cell of umbilical cord and separating and augmenting stem cell
CN107022521A (en) Decidua vera tissue freezing, the method recovered and be separately cultured mescenchymal stem cell
CN102907416A (en) Tissue cryopreservation liquid capable of maintaining cell activity
KR101321144B1 (en) Vitrification medium for stem cells and vitrification method for stem cells using the same
CN105420179A (en) Method for simultaneously extracting epithelial cells and mesenchymal stem cells from umbilical cord and placenta amnion tissues
CN107974429A (en) A kind of method and Optimal Medium of quick separating culture human airway epithelial cells
CN104523753A (en) Preparation method, product and application of human umbilical cord mesenchymal stem cell cultural supernatant active factor and cell lysis buffer
CN103215223B (en) Method for constructing in vitro model of interaction of human intervertebral disc nucleus pulposus cell and immune cell
CN110050780A (en) Frozen stock solution and its application in umbilical cord mesenchymal stem cells freeze
CN104472474A (en) Human adipose tissue-derived stromal cell frozen stock solution
CN102978154A (en) Primary culture method for simultaneously separating skin fibroblasts and epidermis cells of Inner mongolia white cashmere goat
CN108728408A (en) Dog fetal membrane mescenchymal stem cell and preparation method and the culture medium used
CN103289950A (en) Methods for in vitro separation, culture, preservation and recovery of milk cow omasum epithelial cells
CN105219697A (en) A kind of people's primary keratinocyte is separated the method for preparation
CN104894056B (en) A kind of construction method of acipenser dabryanus spleen tissue cell line
CN103451150A (en) Preparation method of placenta source matrix mesenchymal stem cell
CN106035315B (en) Cow mammary gland tissue freezing solution for cow mammary gland epithelial cells original cuiture and its application in breast tissue cryopreservation methods
CN108293980A (en) A kind of neural molecular biology glass frozen preservation/method for resuscitation
CN104894088A (en) Digestive enzyme composition and application thereof, and isolated culture method of umbilical epithelial cells
RU2620981C2 (en) Method of obtaining the culture of mesenchymal human stem cells from the perivascular space of the vein of umbilical cord
CN109161526A (en) A kind of chorion mescenchymal stem cell recovery medium

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20160106